Patients with relapsed/refractory multiple myeloma could benefit from repeat treatment with drugs their disease has ...

Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related ...

Discover a trial in which patients received either IL-2 or a placebo for 5 days, followed by weekly doses for 4 weeks.

PATIENTS with traumatic brain injury (TBI) and hypotension have a significantly increased risk of mortality, underscoring the importance of precise blood pressure management in clinical settings.

NOVEL molecular regulators of rheumatoid arthritis (RA) inflammation were presented as part of a plenary abstract session at ...

CAR T-cell therapy shows promise for solid tumors like glioblastoma. New engineering strategies and clinical trial results ...

A new report reveals high rates of preventable pregnancy-related cardiovascular deaths, underscoring racial disparities and ...

Revisto has raised $4m in seed funding to simplify the pharmaceutical industry's marketing compliance processes using AI.

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation ...

Testing for low placental growth factor during routine gestational diabetes screening could identify pregnant individuals at ...

A recent study explores how MYCN-driven neuroblastoma hijacks the m6A modification process to prevent proper cell ...

Explore the latest insights into the multifaceted aspects of prostate cancer (PCa) treatment presented at the 2024 European Association of Urology (EAU) Congress in Paris, France. The session delved ...